Accounts receivable rose 11.8% at The New York Times in the latest three months, slightly faster than revenue. That is the oddest number in a report otherwise presenting a reassuring pattern.
Revenue reached $762.5 million, up 11.2% from the comparable three months a year earlier. Operating income rose 10.8% to $118.0 million, while diluted earnings per share climbed 14.0% to $0.57. The business sold more and earned more, with one conspicuous detail: operating margin stayed at 15.5%.
That leaves a less dramatic read on the growth. The Times is expanding at a double-digit rate, yet the additional sales are not widening the operating spread. Research and development rose 10.0%, and stock compensation rose 12.3% to $20.0 million. The company does not disclose a single operating explanation for the flat margin in the supplied filing receipts.
Cash generation supplied another development. Cash rose 17.4% to $232.7 million, and free-cash-flow margin improved by 3.4 percentage points. Capital spending increased 6.4%, but spending intensity declined relative to revenue. That means the latest period produced better cash conversion without a corresponding expansion in operating margin.
The numbers also show why the balance-sheet detail matters. Accounts receivable increased by $24.9 million, compared with a $76.6 million increase in revenue. The gap is not large enough to define the whole report, but it is the one place where the cash story asks for more detail rather than less.
The company’s language on future disclosure is notably broad:
"The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise."
The New York Times Company, Form 10-Q, August 5, 2026
That language is not an explanation of the three months. In plain English, the report gives a set of current numbers while leaving the operating reason for unchanged margins unstated.
The backdrop is a business that has been building profitability over time. Annual revenue rose from $2.6 billion in 2024 to $2.8 billion in 2025, while operating margin reached 15.3% from 13.6%. The latest three months extend the sales and earnings progression, but they do not add another step to the operating-margin trend.
At the latest close, NYT shares were $75.65, up 0.3% for the day. The latest annual valuation was 36.3 times earnings, so the filing’s central contrast is fairly specific: the growth rate is visible, the cash conversion is better, and the margin expansion paused. The unresolved question is whether the flat operating margin reflects the company’s current investment pace or something more specific in the revenue mix, a distinction the New York Times’ next quarterly report would have to address through its operating margin and accounts receivable disclosures.
